Update on Kawasaki disease: Epidemiology, aetiology and pathogenesis

Journal of Paediatrics and Child Health

Volumn 49, Issue 9, 2013, Pages 704-708

  Yim, Deane ^a   Curtis, Nigel ^a,b   Cheung, Michael ^a,b   Burgner, David ^a,b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

aetiology; Kawasaki disease; pathogenesis; review

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR;

ASIAN AMERICAN; AUSTRALIA; CHILDHOOD DISEASE; CHROMOSOME 19; CORONARY ARTERY; CORONARY ARTERY ANEURYSM; DISEASE ACTIVITY; GENETIC ASSOCIATION; GENETIC RISK; HOST SUSCEPTIBILITY; HUMAN; IMMUNE RESPONSE; INCIDENCE; INFLAMMATORY CELL; INTESTINE FLORA; JAPAN; KOREA; MAJOR HISTOCOMPATIBILITY COMPLEX; METEOROLOGY; MORBIDITY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEW ZEALAND; PATHOGENESIS; PEDIATRICIAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SEASONAL VARIATION; TAIWAN; TOXIC SHOCK SYNDROME;

AETIOLOGY; KAWASAKI DISEASE; PATHOGENESIS; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUCOCUTANEOUS LYMPH NODE SYNDROME; WORLD HEALTH;

EID: 84883825160     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12172     Document Type: Review

References (67)

1. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996; 94: 1379-1385.
2. Kawasaki T,. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Allergy 1967; 16: 178-222.
3. Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 1986; 315: 341-347.
4. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114: 1708-1733.
5. Burns JC, Glode MP,. Kawasaki syndrome. Lancet 2004; 364: 533-544.
6. Harnden A, Takahashi M, Burgner D,. Kawasaki disease. BMJ 2009; 338: b1514.
7. Nakagawa N, Yoshida M, Narahara K, Kunitomi T,. Kawasaki disease in an 8-day-old neonate. Pediatr. Cardiol. 2009; 30: 527-529.
8. Stanley TV, Grimwood K,. Classical Kawasaki disease in a neonate. Arch. Dis. Child. Fetal Neonatal Ed. 2002; 86: F135-136.
9. Stankovic K, Miailhes P, Bessis D, Ferry T, Broussolle C, Seve P,. Kawasaki-like syndromes in HIV-infected adults. J. Infect. 2007; 55: 488-494.
10. Pannaraj PS, Turner CL, Bastian JF, Burns JC,. Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr. Infect. Dis. J. 2004; 23: 789-791.
11. Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J. Epidemiol. 2012; 22: 216-221.
12. Park YW, Han JW, Hong YM, et al. Epidemiological features of Kawasaki disease in Korea, 2006-2008. Pediatr. Int. 2010; 53: 36-39.
13. Huang WC, Huang LM, Chang IS, et al. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics 2009; 123: e401-405.
14. Lin YT, Manlhiot C, Ching JC, et al. Repeated systematic surveillance of Kawasaki disease in Ontario from 1995 to 2006. Pediatri. Int. 2010; 52: 699-706.
15. Singh S, Aulakh R,. Kawasaki disease and Henoch Schonlein purpura: changing trends at a tertiary care hospital in north India (1993-2008). Rheumatol. Int. 2009; 30: 771-774.
16. Harnden A, Alves B, Sheikh A,. Rising incidence of Kawasaki disease in England: analysis of hospital admission data. BMJ 2002; 324: 1424-1425.
17. Royle JA, Williams K, Elliott E, et al. Kawasaki disease in Australia, 1993-95. Arch. Dis. Child. 1998; 78: 33-39.
18. Heaton P, Wilson N, Nicholson R, Doran J, Parsons A, Aiken G,. Kawasaki disease in New Zealand. J. Paediatr. Child Health 2006; 42: 184-190.
19. Harnden A, Mayon-White R, Perera R, Yeates D, Goldacre M, Burgner D,. Kawasaki disease in England: ethnicity, deprivation, and respiratory pathogens. Pediatr. Infect. Dis. J. 2009; 28: 21-24.
20. Holman RC, Christensen KY, Belay ED, et al. Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med. J. 2010; 69: 194-197.
21. Burgner D, Harnden A,. Kawasaki disease: what is the epidemiology telling us about the etiology? Int. J. Infect. Dis. 2005; 9: 185-194.
22. Carter RF, Haynes ME, Morton J,. Rickettsia-like bodies and splenitis in Kawasaki disease. Lancet 1976; 2: 1254-1255.
23. Singh S, Aulakh R, Bhalla AK, et al. Is Kawasaki disease incidence rising in Chandigarh, North India? Arch. Dis. Child. 2011; 96: 137-140.
24. Chang RK., Hospitalizations for Kawasaki disease among children in the United States, 1988-1997. Pediatrics 2002; 106: e87.
25. Du ZD, Zhang T, Liang L, et al. Epidemiologic picture of KD in Beijing from 1995 through 1999. Pediatr. Infect. Dis. J. 2002; 21: 103-107.
26. Yanagawa H, Yashiro M, Nakamura Y, Kawasaki T, Kato H,. Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan. Arch. Paediatr. Adolesc. Med. 1995; 149: 779-783.
27. Bronstein DE, Dille AN, Austin JP, Williams CM, Palinkas LA, Burns JC,. Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998. Pediatr. Infect. Dis. J. 2000; 19: 1087-1091.
28. Nakamura Y, Yanagawa I, Kawasaki T,. Temporal and geographical clustering of Kawasaki disease in Japan. Prog. Clin. Biol. Res. 1987; 250: 19-32.
29. Rodo X, Ballester J, Cayan D, et al. Association of KD with tropospheric wind patterns. Sci. Rep. 2011; 1: 152.
30. Nakamura Y, Yashiro M, Uehara R, Oki I, Watanabe M, Yanagawa H,. Monthly observation of the number of patients with Kawasaki disease and its incidence rates in Japan: chronological and geographical observation from nationwide surveys. J. Epidemiol. 2008; 18: 273-279.
31. Carman PG, Menahem S,. Possible 'outbreak' of Kawasaki disease in Victoria. Med. J. Aust. 1983; 2: 183-185.
32. Nomura Y, Yoshinaga M, Masuda K, Takei S, Miyata K,. Maternal antibody against toxic shock syndrome toxin-1 may protect infants younger than 6 months of age from developing Kawasaki syndrome. J. Infect. Dis. 2002; 185: 1677-1680.
33. Hirata S, Nakamura Y, Yanagawa H,. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001; 90: 40-44.
34. Langley R, Patel D, Jackson N, Clow F, Fraser JD,. Staphylococcal superantigen super-domains in immune evasion. Crit. Rev. Immunol. 2010; 30: 149-165.
35. Yeung RS,. Kawasaki disease: update on pathogenesis. Curr. Opin. Rheumatol. 2010; 22: 551-560.
36. Rowley AH, Shulman ST, Garcia FL, et al. Cloning the arterial IgA antibody response during acute Kawasaki disease. J. Immunol. 2005; 175: 8386-8391.
37. Rowley AH, Baker SC, Shulman ST, et al. Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a 'new' virus associated with Kawasaki disease. J. Infect. Dis. 2011; 203: 1021-1030.
38. Curtis N,. Kawasaki disease. BMJ 1997; 315: 322-323.
39. Curtis N,. Kawasaki disease and toxic shock syndrome-at last the etiology is clear? Adv. Exp. Med. Biol. 2004; 549: 191-200.
40. Leung DY, Giorno RC, Kazemi LV, Flynn PA, Busse JB,. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J. Immunol. 1995; 155: 5018-5021.
41. Brogan PA, Shah V, Clarke LA, Dillon MJ, Klein N,. T cell activation profiles in Kawasaki syndrome. Clin. Exp. Immunol. 2008; 151: 267-274.
42. Curtis N, Zheng R, Lamb JR, Levin M,. Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 1995; 72: 308-311.
43. Brogan PA, Shah V, Bagga A, Klein N, Dillon MJ,. T cell Vbeta repertoires in childhood vasculitides. Clin. Exp. Immunol. 2003; 131: 517-527.
44. Matsubara K, Fukaya T, Miwa K, et al. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin. Exp. Immunol. 2006; 143: 427-434.
45. Suenaga T, Suzuki H, Shibuta S, Takeuchi T, Yoshikawa N,. Detection of multiple superantigen genes in stools of patients with Kawasaki disease. J. Pediatr. 2009; 155: 266-270.
46. Curtis N, Chan B, Levin M,. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1994; 343: 299.
47. Nagata S, Yamashiro Y, Ohtsuka Y, et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology 2009; 128: 511-520.
48. Hamaoka K, Onouchi Z, Kamiya Y, Sakata K,. Evaluation of coronary flow velocity dynamics and flow reserve in patients with Kawasaki disease by means of a Doppler guide wire. J. Am. Coll. Cardiol. 1998; 31: 833-840.
49. Fujita Y, Nakamura Y, Sakata K, et al. Kawasaki disease in families. Pediatrics 1989; 84: 666-669.
50. Uehara R, Yashiro M, Nakamura Y, Yanagawa H,. Kawasaki disease in parents and children. Acta Paediatr. 2003; 92: 694-697.
51. Uehara R, Yashiro M, Nakamura Y, Yanagawa H,. Clinical features of patients with Kawasaki disease whose parents had the same disease. Arch. Pediatr. Adolesc. Med. 2004; 158: 1166-1169.
52. Biezeveld MH, van Mierlo G, Lutter R, et al. Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin. Exp. Immunol. 2005; 141: 183-188.
53. Popper SJ, Shimizu C, Shike H, et al. Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol. 2007; 8: R261.
54. Chun JK, Kang DW, Yoo BW, Shin JS, Kim DS,. Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease. Eur. J. Pediatr. 2010; 169: 181-185.
55. Onouchi Y, Ozaki K, Buns JC, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum. Mol. Genet. 2010; 19: 2898-2906.
56. Lau AC, Duong TT, Ito S, Yeung RS,. Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease. Arthritis Rheum. 2008; 58: 854-863.
57. Gavin PJ, Crawford SE, Shulman ST, Garcia FL, Rowley AH,. Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 576-581.
58. Chua PK, Melish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR,. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin. Diagn. Lab. Immunol. 2003; 10: 308-314.
59. Park JA, Shin KS, Kim YW,. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease. J. Korean Med. Sci. 2005; 20: 607-611.
60. Shimizu C, Matsubara T, Onouchi Y, et al. Matrix metalloproteinase haplotypes associated with coronary artery aneurysm formation in patients with Kawasaki disease. J. Hum. Genet. 2010; 55: 779-784.
61. Onouchi Y, Tamari M, Takahashi A, et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J. Hum. Genet. 2007; 52: 179-190.
62. Onouchi Y, Gunji T, Burns JC, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat. Genet. 2008; 40: 35-42.
63. Chi H, Huang FY, Chen MR, et al. ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children. Hum. Mol. Genet. 2010; 19: 1147-1151.
64. Burgner D, Davila S, Breunis WB, et al. A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet. 2009; 5: e1000319.
65. Kim JJ, Hong YM, Sohn S, et al. A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum. Genet. 2011; 129: 487-495.
66. Tsai FJ, Lee YC, Chang JS, et al. Identification of novel susceptibility Loci for Kawasaki disease in a Han Chinese population by a genome-wide association study. PloS ONE 2011; 6: e16853.
67. Khor CC, Davila S, Breunis WB, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat. Genet. 2011; 43: 1241-1246